451 patents
Page 3 of 23
Utility
Methods and Apparatus for Displaying Glucose Data
19 Oct 23
The techniques described herein relate to computerized methods and apparatus for displaying glucose data.
Richard Anthony ARMADA, Nathan Louis BILANCIO, Kenneth Charles SPRY, Jr.
Filed: 25 Aug 21
Utility
Injection device with plunger arrangment and converging ramps
17 Oct 23
An injection device is disclosed including a housing assembly defining a pair of ramps and adapted to hold a medicament cartridge.
Jared Alden Judson
Filed: 25 Apr 18
Utility
Glucocorticoid receptor agonists
17 Oct 23
Adel Ahmed Rashad Ahmed, Joshua Ryan Clayton, Jose Eduardo Lopez, William Thomas McMillen, Ryan Edward Stites, Takako Wilson, Jacqueline Mary Wurst
Filed: 22 Mar 22
Utility
Therapeutic Antibody Formulations
12 Oct 23
Stable pharmaceutical formulations for therapeutic anti-IL-23p19 antibodies and methods of using such stable pharmaceutical formulations.
Aaron Paul Markham, Galen Huaiqiu Shi, Justin Cody Thomas
Filed: 10 Sep 21
Utility
Medication Delivery Device Including Disposable and Reusable Portions
5 Oct 23
A medication delivery device includes a disposable portion and a reusable portion.
Matthew David BACKFISH, Murat GÜNAY
Filed: 22 Oct 21
Utility
Compounds Useful for Inhibiting Ret Kinase
5 Oct 23
Erin D. ANDERSON, Steven W. ANDREWS, Kevin R. CONDROSKI, Thomas C. IRVIN, Gabrielle R. KOLAKOWSKI, Manoj KUMAR, Elizabeth A. MCFADDIN, Megan MCKENNEY, Michael J. MUNCHHOF, Michael B. WELCH
Filed: 6 Feb 23
Utility
(Trifluoromethyl)pyrimidine-2-amine compounds
3 Oct 23
Daryl Lynn Smith, Leonard Larry Winneroski, Jr.
Filed: 25 Jul 22
Utility
Medication delivery device with mechanical locking system
3 Oct 23
A medication delivery device having a lock element.
Roy Howard Byerly, Kimberly Ann Ringenberger
Filed: 10 Dec 21
Utility
Medication delivery device with sensing system
3 Oct 23
Medication delivery devices are provided having a dose delivery sensing capability.
Roy Howard Byerly, Daniel Joseph Nelsen, Russell Wayne Perkins, Robert Charles Uschold
Filed: 4 Aug 22
Utility
Nasal Powder Formulation for Treatment of Hypoglycemia
28 Sep 23
The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia.
Sankaram MANTRIPRAGADA, Claude A. PICHE, Jo Jan Filip VAN BETSBRUGGE
Filed: 10 Feb 23
Utility
Nasal Delivery Device
28 Sep 23
The present disclosure provides a nasal delivery device with a device body that includes a trigger end and an outlet end.
Jaime Ray ARNETT
Filed: 17 May 23
Utility
Methods and Systems for Selecting an Injection Site
21 Sep 23
Methods and systems are provided for evaluating injection sites on a body of a patient.
Hemant Thakorbhai PATEL, Louis Stevens SOMLAI, Adam Nathaniel WIESLER
Filed: 14 Jul 22
Utility
Method of Using a GIP/GLP1 Co-agonist for Diabetes
21 Sep 23
The present invention provides methods of treating type 2 diabetes (T2D) using a novel dosing regimen of a GIP:GLP-1 Peptide having a GIP:GLP-1 receptor agonist potency ratio that is about 2.5:1 to about 10:1 GIP to GLP-1.
Jorge ALSINA-FERNANDEZ, Over CABRERA, Tamer COSKUN
Filed: 22 Jul 19
Utility
Medication Delivery Device Including Disposable and Reusable Portions
21 Sep 23
A medication delivery device including a disposable portion and a reusable portion.
Caroline Grace Pyne JOHNSON, Adam Nathaniel WIESLER
Filed: 23 Aug 21
Utility
Treatment of Respiratory Disease
21 Sep 23
Methods of preventing and/or treating ARDS with anti-IL17 antibodies, including dose regimens and pharmaceutical formulations of anti-IL17 antibodies for use in the prevention and/or treatment of ARDS.
Gaia GALLO, Venkatesh KRISHNAN, Sreekumar G. PILLAI, Brian Jeffrey NICKOLOFF
Filed: 26 Sep 22
Utility
Prevention of Axonal Damage Using Antibody Binding to Amyloid Beta 1-42
14 Sep 23
The present invention relates to the prevention of neuronal axonal damage.
Keith Tan, Craig Shering, John R. Sims, Jeffrey L. Dage
Filed: 25 Jun 21
Utility
Compounds and Methods Targeting INTERLEUKIN-34
7 Sep 23
The present invention relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Marcio Chedid, Victor H. Obungu, Andrew Dixon Skora, Ming Ye
Filed: 7 Apr 23
Utility
ANTI-CD137 Antibodies
7 Sep 23
The present invention relates to antibodies that bind to human CD137 and display agonist activity, and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and ionizing radiation.
Christopher Carl FRYE, Michael Dewain KALOS, Helen KOTANIDES, Stephanie Lynn SANDEFUR
Filed: 1 Nov 22
Utility
Compounds and Methods Targeting INTERLEUKIN-34
7 Sep 23
The present disclosure relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer’s Disease or a tauopathy disease.
Marcio Chedid, Adam S. Fleisher, Megan Brittany Lannan, Albert Lo, Mark Mintun, Victor H. Obungu, Sarah Elisabeth Raines, John Randall Sims, II, Andrew Dixon Skora, Robin Elizabeth Walsh, Elizabeth Anne West, Ming Ye
Filed: 27 Oct 22
Utility
Selective estrogen receptor degraders
5 Sep 23
Kenneth Charles Cassidy, Kishore Kumar Katyayan
Filed: 10 Mar 22